CN1301714C - 酰氨基亚链烯基酰胺衍生物在功能性内脏能动性疾病中的应用 - Google Patents

酰氨基亚链烯基酰胺衍生物在功能性内脏能动性疾病中的应用 Download PDF

Info

Publication number
CN1301714C
CN1301714C CNB038034859A CN03803485A CN1301714C CN 1301714 C CN1301714 C CN 1301714C CN B038034859 A CNB038034859 A CN B038034859A CN 03803485 A CN03803485 A CN 03803485A CN 1301714 C CN1301714 C CN 1301714C
Authority
CN
China
Prior art keywords
hydrogen
phenyl
methyl
alkyl
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB038034859A
Other languages
English (en)
Chinese (zh)
Other versions
CN1627947A (zh
Inventor
J·R·福扎德
E·韦伯
H-J·普凡库赫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN1627947A publication Critical patent/CN1627947A/zh
Application granted granted Critical
Publication of CN1301714C publication Critical patent/CN1301714C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
CNB038034859A 2002-02-08 2003-02-07 酰氨基亚链烯基酰胺衍生物在功能性内脏能动性疾病中的应用 Expired - Fee Related CN1301714C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0203061.7 2002-02-08
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds

Publications (2)

Publication Number Publication Date
CN1627947A CN1627947A (zh) 2005-06-15
CN1301714C true CN1301714C (zh) 2007-02-28

Family

ID=9930743

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038034859A Expired - Fee Related CN1301714C (zh) 2002-02-08 2003-02-07 酰氨基亚链烯基酰胺衍生物在功能性内脏能动性疾病中的应用

Country Status (18)

Country Link
US (2) US20050203164A1 (enExample)
EP (2) EP1476167A1 (enExample)
JP (2) JP2005516994A (enExample)
KR (2) KR20040081492A (enExample)
CN (1) CN1301714C (enExample)
AU (1) AU2003244446B2 (enExample)
BR (1) BR0307479A (enExample)
CA (1) CA2471964A1 (enExample)
GB (1) GB0203061D0 (enExample)
IL (2) IL162816A0 (enExample)
MX (1) MXPA04007640A (enExample)
NO (1) NO20043735L (enExample)
NZ (1) NZ534231A (enExample)
PL (1) PL370255A1 (enExample)
RU (1) RU2353356C2 (enExample)
TW (1) TWI330177B (enExample)
WO (1) WO2003066062A1 (enExample)
ZA (1) ZA200404960B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
CA2543552A1 (en) * 2003-10-27 2005-05-06 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
CN101568331A (zh) 2006-09-08 2009-10-28 奥尔制药有限公司 减少或缓解消化道炎症的方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1119101A (zh) * 1994-06-03 1996-03-27 伊莱利利公司 噻吩并[1，5]苯并二氨杂䓬的用途
CN1179102A (zh) * 1995-03-24 1998-04-15 伊莱利利公司 2－甲基－噻吩并－苯并二氮杂䓬口服制剂
US5929067A (en) * 1995-02-22 1999-07-27 Novartis Ag 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
US6319917B1 (en) * 1996-08-22 2001-11-20 Novartis Ag Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
CN1333771A (zh) * 1998-11-20 2002-01-30 明治制果株式会社 苯并噁唑衍生物及含有该衍生物作为有效成份的药物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
TR199903299T2 (xx) * 1997-07-02 2000-07-21 Merck & Co., Inc. Ta�ikinin resept�r antagonisti 2-(R)-(1-(R)- (3,5-Bis(triflorometil) Fenil)Etoksi-3-(S)- (4-Floro)Fenil-4- (3-5(-okso-1H,4H-1,2,4-Triazolo) metilmorfolin'in polimorfik formu.
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
CA2432543A1 (en) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Combination drugs
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1119101A (zh) * 1994-06-03 1996-03-27 伊莱利利公司 噻吩并[1，5]苯并二氨杂䓬的用途
US5929067A (en) * 1995-02-22 1999-07-27 Novartis Ag 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
CN1179102A (zh) * 1995-03-24 1998-04-15 伊莱利利公司 2－甲基－噻吩并－苯并二氮杂䓬口服制剂
US6319917B1 (en) * 1996-08-22 2001-11-20 Novartis Ag Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
CN1333771A (zh) * 1998-11-20 2002-01-30 明治制果株式会社 苯并噁唑衍生物及含有该衍生物作为有效成份的药物

Also Published As

Publication number Publication date
AU2003244446A1 (en) 2003-09-02
RU2353356C2 (ru) 2009-04-27
NO20043735L (no) 2004-09-07
US20050203164A1 (en) 2005-09-15
JP2005516994A (ja) 2005-06-09
PL370255A1 (en) 2005-05-16
AU2003244446B2 (en) 2006-08-10
TWI330177B (en) 2010-09-11
EP2216025A3 (en) 2010-11-10
HK1077749A1 (en) 2006-02-24
KR20100100994A (ko) 2010-09-15
BR0307479A (pt) 2004-12-07
CA2471964A1 (en) 2003-08-14
US20070293473A1 (en) 2007-12-20
TW200302818A (en) 2003-08-16
KR20040081492A (ko) 2004-09-21
GB0203061D0 (en) 2002-03-27
CN1627947A (zh) 2005-06-15
EP2216025A2 (en) 2010-08-11
JP2010241835A (ja) 2010-10-28
IL162816A (en) 2010-11-30
IL162816A0 (en) 2005-11-20
RU2004127132A (ru) 2005-06-10
MXPA04007640A (es) 2004-11-10
NZ534231A (en) 2007-02-23
ZA200404960B (en) 2006-05-31
EP1476167A1 (en) 2004-11-17
WO2003066062A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
CN1206996C (zh) 用于治疗或预防睡眠障碍的药物组合物
CN1145619C (zh) 1,4-苯并硫杂吖庚因衍生物、其制备方法、含有该化合物的药物及其用途
CN1711085A (zh) 含乙酸酰基苯胺衍生物作为活性成分的膀胱活动过度的治疗药物
CN1269483C (zh) 新用途
CN1155276A (zh) 酶抑制剂
CN1893948A (zh) 蕈毒碱性乙酰胆碱受体拮抗剂
CN1196681C (zh) (+)诺西沙必利用于制备5－ht3和5ht4 介导的疾病的药物中的用途
CN1142228A (zh) 新的氨基酸衍生物，其制备方法及含该化合物的药物组合物
CN1627947A (zh) 酰氨基亚链烯基酰胺衍生物在功能性内脏能动性疾病中的应用
CN101076328A (zh) 用于睡眠障碍的预防或治疗剂
CN1085979C (zh) 麻药型镇痛剂依赖性/抗性形成抑制剂
CN1610548A (zh) 依贝沙坦在制备用来预防或治疗肺动脉高压的药物中的应用
CN1311677A (zh) 顽固性癫痫的治疗剂或预防剂
HK1077749B (en) Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
CN1268938A (zh) 氨基环烷烃化合物
CN1233643C (zh) 一种药物化合物的衍生物及其制备方法和应用
CN101052386A (zh) 儿科使用的基于nk2拮抗剂的药物组合物
CN1874766A (zh) 神经激肽拮抗剂在尿失禁治疗中的用途
CN1407892A (zh) 间歇性跛行治疗药
HK1145139A (en) Use of acylaminoalkenylene-amide derivatives in irritable bowel syndrome and functional dyspepsia
WO2004063201A1 (ja) 統合失調症治療剤
HK1098680A (en) Kv1.5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency
CN1415305A (zh) 罗红霉素缓释制剂
CN1440281A (zh) 降眼压药
CN1688309A (zh) 5－ht2受体拮抗剂在治疗睡眠障碍中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1077749

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070228

Termination date: 20120207